The fact of matter is, millions of lives have already been saved with AMRS technology and that process is moving to mainstream drug discovery by all. There is now a bevy of new options on drug discovery that we didn't have before AMRS....
Why do you think the largest and most powerful companies want to partner/collaborate with us, they like our logo? This technology could very well be the one that saves my, or you life in a few years.
Amyris Scientists Describe Breakthrough in Development of Anti-Malarial Drug Precursor Sanofi Utilizing Amyris Engineered Yeast Strains to Produce Life-Saving Drug Ingredient at Scale
Malaria is a preventable disease that affects over a quarter of a billion people and claims the lives of 650,000 people annually, mostly children under the age of five in Africa. Artemisinin, sourced from the wormwood plant, Artemisia annua, has been used for centuries in treating malaria but its availability, cost and quality have been highly volatile.
Working with a number of partners, and with generous support from the Bill & Melinda Gates Foundation via OneWorld Health (now PATH's Drug Development Program), Amyris developed technology to convert plant-sugars into Artemisinic Acid, a late stage precursor to the anti-malarial drug ingredient, Artemisinin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.